磁共振引导聚焦超声治疗震颤:美国立体定向与功能神经外科学会立场声明的更新
美国立体定向与功能神经外科学会更新了MRgFUS丘脑毁损术治疗震颤的立场声明。在特发性震颤中,多项开放标签研究和1项前瞻性双盲假手术对照随机临床试验支持其疗效,短期手部震颤改善47%,长期随访显示获益持续;帕金森病震颤的短期改善有证据支持,但长期效果尚不明确。
要点
- MRgFUS丘脑毁损术是药物难治性特发性震颤安全、有效且持久的干预手段。
- 特发性震颤短期手部震颤改善47%,长期随访显示获益持续。
- 帕金森病震颤短期改善显著,但长期疗效未知,长期耐久性仍是顾虑。
核心结论
- MRgFUS丘脑毁损术对经过适当选择的药物难治性特发性震颤患者是安全、有效且持久的干预。
- 该手术对帕金森病震颤似乎安全有效,但该技术的长期耐久性仍是顾虑。
- 特发性震颤双侧分期毁损的早期经验提示该手术安全有效。
研究设计与样本
- 美国立体定向与功能神经外科学会代表神经外科医师大会和美国神经外科医师协会,就MRgFUS治疗震颤的适应证、疗效与安全性发布立场声明更新。
- 特发性震颤证据包括多项开放标签研究、1项前瞻性双盲假手术对照随机临床试验及长期随访研究,另有双侧分期MRgFUS丘脑毁损术的研究。
- 帕金森病震颤证据包括1项以较小规模非随机研究为主的系统Meta分析、1项随机临床试验和1项前瞻性队列研究。
诊断标准与关键数值
- 特发性震颤:1项前瞻性双盲假手术对照随机临床试验显示短期手部震颤改善47%。
- 特发性震颤:随访研究显示MRgFUS的获益长期持续。
- 特发性震颤:双侧分期MRgFUS丘脑毁损术研究显示,第二侧术后震颤改善与第一侧术后观察到的一样显著。
- 帕金森病震颤:短期改善显著,但长期效果仍未知。
临床应用与阅片要点
- MRgFUS丘脑毁损术适用于经过适当选择的药物难治性特发性震颤患者。
- 帕金森病震颤可考虑该手术,但长期耐久性仍是顾虑。
- 常见早期不良反应包括步态障碍和感觉异常,这些反应往往随时间消退。
- 其他报告的不良反应包括构音障碍、共济失调、味觉障碍、运动缺损和言语困难。
局限性
- 帕金森病震颤的长期效果仍未知。
- 帕金森病震颤证据主要来自较小规模的非随机研究。
- 帕金森病震颤的长期耐久性仍是顾虑。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy has become a popular tool in the neurosurgical armamentarium for managing tremor in patients with essential tremor (ET) and Parkinson's disease (PD).
METHODS: Given the recent exponential growth in the use of this technology, the American Society for Stereotactic and Functional Neurosurgery, which acts as the joint section representing the field of stereotactic and functional neurosurgery on behalf of the Congress of Neurological Surgeons and the American Association of Neurological Surgeons, provides an update on treatment indications and the efficacy and safety of MRgFUS for the treatment of tremor.
RESULTS: In ET, the efficacy of MRgFUS thalamotomy is supported by several open-label and 1 prospective, double-blind, sham-controlled randomized clinical trial (RCT) that showed a 47% improvement in hand tremor in the short term. Follow-up studies demonstrated that the benefits of MRgFUS for ET are sustained in the long term. Studies investigating the effects of bilateral staged MRgFUS thalamotomy in patients with ET have shown that tremor improvement on the second side was as significant as that observed after the first procedure. The efficacy of MRgFUS thalamotomy for PD tremor is supported by a systematic meta-analysis that consisted predominantly of smaller, nonrandomized studies; 1 RCT; and 1 prospective cohort study. Despite a significant short-term improvement in PD tremor, the long-term effects of this therapy remain unknown. Common early adverse effects of MRgFUS thalamotomy include gait disturbance and paresthesias. These, however, tend to subside over time. Other reported side effects are dysarthria, ataxia, taste disturbance, motor deficits, and speech difficulty.
CONCLUSIONS: MRgFUS thalamotomy is a safe, effective, and durable intervention for refractory ET in appropriately selected patients. The procedure appears to be safe and effective for PD tremor, although the long-term durability of the technique remains a concern. Early experience with bilateral staged lesions for ET suggests the procedure to be safe and effective.
引用
- Hamani C, Elias WJ, Baltuch GH, et al. Magnetic resonance-guided focused ultrasound for the management of tremor: update on the position statement of the American Society for Stereotactic and Functional Neurosurgery. J Neurosurg. 2026. PMID: 41894813. doi:10.3171/2025.11.JNS251828
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。